STOCK WARRANTS (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
1 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Dec. 31, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2016 |
|
Number of issued warrants exercisable | ||||
Issuance of common stock upon exercise of warrants | 345,878 | |||
Net proceeds from warrants exercise | $ 707 | $ 861 | ||
Warrants intrinsic value | $ 58 | |||
Common Stock [Member] | ||||
Warrant to purchase shares of common stock | 225,878 | |||
Issuance of common stock upon exercise of warrants | 225,878 | |||
Warrants exercise price | $ 3.13 | |||
Net proceeds from warrants exercise | $ 707 | |||
Stock issued during the period | 61,644 | |||
Private Placement [Member] | Warrant [Member] | ||||
Number of issued warrants exercisable | 370,000 | |||
July 2020 Private Placement [Member] | Warrant [Member] | ||||
Number of issued warrants exercisable | 250,000 | |||
Underwritten Public Offering [Member]. | Maximum [Member] | ||||
Warrant to purchase shares of common stock | 120,000 | |||
Cashless Transaction [Member] | Common Stock [Member] | ||||
Warrant to purchase shares of common stock | 120,000 |
X | ||||||||||
- Definition Warrants intrinsic value. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|